Mural Oncology (MURA)
NASDAQ: MURA
· Real-Time Price · USD
1.77
0.00 (0.00%)
At close: Aug 15, 2025, 3:59 PM
1.79
1.13%
After-hours: Aug 15, 2025, 05:02 PM EDT
Mural Oncology Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
Net Income | -47.98M | -33.14M | -34.27M | -31.76M | -31.56M | -30.92M | -59.54M | -51.28M | -50.16M | -46.47M | -48.58M | -50.64M |
Depreciation & Amortization | 1.14M | 851K | 868K | 898K | 899K | 846K | 613K | 779K | 645K | 530K | 497K | 372K |
Stock-Based Compensation | -1.12M | 513K | 662K | 1.03M | 1.19M | 2.2M | 15.23M | 2.98M | 3.14M | 2.75M | 3.2M | 3.48M |
Other Working Capital | n/a | n/a | -751K | 7.19M | 1.59M | -13.12M | 966K | -2.95M | 1.06M | -12.55M | 7M | n/a |
Other Non-Cash Items | 16.6M | -96K | 383K | -7.23M | -2.37M | 238K | 16.46M | n/a | n/a | 3.81M | 4.19M | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -16.46M | n/a | n/a | n/a | -4.19M | n/a |
Change in Working Capital | n/a | -4.93M | 591K | 6.98M | 2.48M | -9.47M | 966K | -2.95M | 1.06M | -12.55M | 7M | 9.49M |
Operating Cash Flow | -31.36M | -36.8M | -31.77M | -30.08M | -29.36M | -37.34M | -42.73M | -50.47M | -45.32M | -55.74M | -37.89M | -37.3M |
Capital Expenditures | -5K | -10K | -23K | -14K | n/a | -55K | -1.18M | -1.17M | -710K | -398K | -143K | -2.7M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | 170K | -23.67M | -19.32M | -124.48M | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 1M | 28M | 36M | 43M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 780K | n/a | 67K | n/a | 63M | n/a | -3.5K | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 1.77M | 27.99M | 36.21M | 19.31M | 43.68M | -124.54M | -1.18M | -1.17M | -710K | -398K | -143K | -2.7M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 28K | n/a | 196K | n/a | n/a | 315.01M | 51.64M | 46.03M | 56.13M | 38.03M | 39.99M |
Financial Cash Flow | n/a | 28K | n/a | 196K | n/a | n/a | 315.01M | 51.64M | 46.03M | 56.13M | 38.03M | 39.99M |
Net Cash Flow | -29.59M | -8.78M | 4.44M | -8.6M | 14.32M | -163.59M | 271.11M | n/a | n/a | n/a | n/a | n/a |
Free Cash Flow | -31.37M | -36.81M | -31.79M | -30.09M | -29.36M | -37.39M | -43.9M | -51.64M | -46.03M | -56.13M | -38.03M | -39.99M |